These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23091635)

  • 1. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs.
    Seehase M; Collins JJ; Kuypers E; Jellema RK; Ophelders DR; Ospina OL; Perez-Gil J; Bianco F; Garzia R; Razzetti R; Kramer BW
    PLoS One; 2012; 7(10):e47631. PubMed ID: 23091635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome.
    Mikolka P; Curstedt T; Feinstein R; Larsson A; Grendar M; Rising A; Johansson J
    Physiol Rep; 2021 Jan; 9(1):e14700. PubMed ID: 33403805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of poractant alfa and lyophilized lucinactant in a preterm lamb model of acute respiratory distress.
    Mazela J; Merritt A; Terry MH; Gregory TJ; Blood AB
    Pediatr Res; 2012 Jul; 72(1):32-7. PubMed ID: 22465908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.
    Mikolka P; Kosutova P; Kolomaznik M; Nemcova N; Hanusrichterova J; Curstedt T; Johansson J; Calkovska A
    Lung; 2024 Jun; 202(3):299-315. PubMed ID: 38684519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
    Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
    Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
    Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
    Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.
    Wolfson MR; Wu J; Hubert TL; Gregory TJ; Mazela J; Shaffer TH
    Pediatr Res; 2012 Oct; 72(4):375-83. PubMed ID: 22821059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B
    PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
    Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
    Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung.
    Sato A; Ikegami M
    PLoS One; 2012; 7(7):e39392. PubMed ID: 22808033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary distribution of lucinactant and poractant alfa and their peridosing hemodynamic effects in a preterm lamb model of respiratory distress syndrome.
    Terry MH; Merritt TA; Harding B; Schroeder H; Merrill-Henry J; Mazela J; Gregory TJ; Segal R; Power GG; Blood AB
    Pediatr Res; 2010 Sep; 68(3):193-8. PubMed ID: 20531255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633.
    Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F
    Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
    van Zyl JM; Smith J
    Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
    Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
    Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs.
    Zecchi R; Franceschi P; Tigli L; Ricci F; Boscaro F; Pioselli B; Mileo V; Murgia X; Bianco F; Salomone F; Schmidt AF; Hillman NH; Kemp MW; Jobe AH
    Respir Res; 2019 Aug; 20(1):175. PubMed ID: 31382955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
    Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
    J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.
    Salvesen B; Curstedt T; Mollnes TE; Saugstad OD
    Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ricci F; Salomone F; Kuypers E; Ophelders D; Nikiforou M; Willems M; Krieger T; Murgia X; Hütten M; Kramer BW; Bianco F
    Front Pediatr; 2017; 5():186. PubMed ID: 28913327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.